Actively Recruiting
Randomized Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women Undergoing Coronary Artery Bypass Grafting
Led by Weill Medical College of Cornell University · Updated on 2026-04-01
2300
Participants Needed
146
Research Sites
N/A
Total Duration
On this page
Sponsors
W
Weill Medical College of Cornell University
Lead Sponsor
N
New York Presbyterian Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the outcomes of different coronary artery bypass grafting techniques in women with heart disease. The trial compares multiple arterial grafting MAG to single arterial grafting SAG to see if using multiple arterial grafts improves major heart and brain-related events and quality of life. This international randomized clinical trial includes 2,300 women to assess differences in survival, stroke, heart attacks, repeat surgeries, and hospital readmissions, as well as physical and mental health. Participants will be randomly assigned to one of two groups. One group receives a single arterial graft using the left internal thoracic artery plus additional venous grafts. The other group receives multiple arterial grafts, including the left internal thoracic artery and at least one other arterial graft such as the right internal thoracic artery or radial artery, with possible additional arterial grafts. The study uses the infrastructure of an existing trial and follows patients for at least 2.5 years after surgery. During the study, researchers collect data on major adverse cardiac and cerebrovascular events, along with quality of life measured by general and disease-specific questionnaires. Physical and mental health symptoms are also assessed. Follow-up includes tracking deaths, strokes, heart attacks, repeat procedures, and hospital stays. The trial aims to provide detailed information on outcomes and quality of life in women undergoing coronary bypass surgery over a long-term period.
CONDITIONS
Brief Title
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 years or older
- Scheduled for isolated coronary artery bypass grafting
- First time undergoing cardiac surgery
- Significant disease of the left main coronary artery or the left anterior descending and circumflex coronary arteries, with or without disease of the right coronary artery
You will not qualify if you...
- Male gender
- Use of a single graft only
- Emergency surgery
- Heart attack within 72 hours before surgery
- Left ventricular ejection fraction less than 35%
- Any other cardiac or non-cardiac procedure planned at the same time
- Previous cardiac surgery
- Severe organ dysfunction before surgery (dialysis, liver failure, respiratory failure), cancer, or other conditions reducing life expectancy under 5 years
- Inability to use the saphenous vein or both radial and right internal thoracic arteries
- Expected need for coronary thrombo-endarterectomy
- Planned hybrid revascularization procedure
Research Team
M
Mario Gaudino, Prof/PhD/MD
S
Stephen Fremes, Prof/MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here